BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28398518)

  • 1. Epigenetic Regulation of CD133 in Gastrointestinal Stromal Tumors.
    Geddert H; Braun A; Kayser C; Dimmler A; Faller G; Agaimy A; Haller F; Moskalev EA
    Am J Clin Pathol; 2017 May; 147(5):515-524. PubMed ID: 28398518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of hematopoietic progenitor cell antigen CD34 is regulated by DNA methylation in a site-dependent manner in gastrointestinal stromal tumours.
    Bure I; Braun A; Kayser C; Geddert H; Schaefer IM; Cameron S; Ghadimi MB; Ströbel P; Werner M; Hartmann A; Wiemann S; Agaimy A; Haller F; Moskalev EA
    Int J Cancer; 2017 Dec; 141(11):2296-2304. PubMed ID: 28744850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression profiling of GIST: CD133 is associated with KIT exon 11 mutations, gastric location and poor prognosis.
    Arne G; Kristiansson E; Nerman O; Kindblom LG; Ahlman H; Nilsson B; Nilsson O
    Int J Cancer; 2011 Sep; 129(5):1149-61. PubMed ID: 21064103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant DNA methylation associated with aggressiveness of gastrointestinal stromal tumour.
    Okamoto Y; Sawaki A; Ito S; Nishida T; Takahashi T; Toyota M; Suzuki H; Shinomura Y; Takeuchi I; Shinjo K; An B; Ito H; Yamao K; Fujii M; Murakami H; Osada H; Kataoka H; Joh T; Sekido Y; Kondo Y
    Gut; 2012 Mar; 61(3):392-401. PubMed ID: 21708825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents.
    Ricci R; Martini M; Ravegnini G; Cenci T; Milione M; Lanza P; Pierconti F; Santini D; Angelini S; Biondi A; Rosa F; Alfieri S; Clemente G; Persiani R; Cassano A; Pantaleo MA; Larocca LM
    Clin Epigenetics; 2019 Jan; 11(1):2. PubMed ID: 30616628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ezrin overexpression in gastrointestinal stromal tumors: an independent adverse prognosticator associated with the non-gastric location.
    Wei YC; Li CF; Yu SC; Chou FF; Fang FM; Eng HL; Uen YH; Tian YF; Wu JM; Li SH; Huang WW; Li WM; Huang HY
    Mod Pathol; 2009 Oct; 22(10):1351-60. PubMed ID: 19648886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PDGFRA Immunohistochemistry Predicts PDGFRA Mutations in Gastrointestinal Stromal Tumors.
    Papke DJ; Forgó E; Charville GW; Hornick JL
    Am J Surg Pathol; 2022 Jan; 46(1):3-10. PubMed ID: 33859072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events.
    Huss S; Pasternack H; Ihle MA; Merkelbach-Bruse S; Heitkötter B; Hartmann W; Trautmann M; Gevensleben H; Büttner R; Schildhaus HU; Wardelmann E
    Hum Pathol; 2017 Apr; 62():206-214. PubMed ID: 28159677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Expression of
    Yuan J; Kihara T; Kimura N; Hashikura Y; Ohkouchi M; Isozaki K; Takahashi T; Nishida T; Ito A; Hirota S
    Pathol Oncol Res; 2021; 27():602008. PubMed ID: 34257559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted ultra-deep sequencing unveils a lack of driver-gene mutations linking non-hereditary gastrointestinal stromal tumors and highly prevalent second primary malignancies: random or nonrandom, that is the question.
    Lai BR; Wu YT; Kuo YC; Hsu HC; Chen JS; Chen TC; Wu RC; Chiu CT; Yeh CN; Yeh TS
    Oncotarget; 2016 Dec; 7(50):83270-83277. PubMed ID: 27806309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exon 11 homozygous mutations and intron 10/exon 11 junction deletions in the KIT gene are associated with poor prognosis of patients with gastrointestinal stromal tumors.
    Shen YY; Ma XL; Wang M; Zhuang C; Ni B; Tu L; Liu Q; Zhao WY; Cao H
    Cancer Med; 2020 Sep; 9(18):6485-6496. PubMed ID: 32697050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of epithelioid morphology and PDGFRA immunostaining pattern for prediction of PDGFRA mutated genotype in gastrointestinal stromal tumors (GISTs).
    Agaimy A; Otto C; Braun A; Geddert H; Schaefer IM; Haller F
    Int J Clin Exp Pathol; 2013; 6(9):1839-46. PubMed ID: 24040448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic inactivation of FAT4 contributes to gastric field cancerization.
    Yoshida S; Yamashita S; Niwa T; Mori A; Ito S; Ichinose M; Ushijima T
    Gastric Cancer; 2017 Jan; 20(1):136-145. PubMed ID: 26792292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
    Miettinen M; Sobin LH; Lasota J
    Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GIST Manifesting as a Retroperitoneal Tumor: Clinicopathologic Immunohistochemical, and Molecular Genetic Study of 112 Cases.
    Miettinen M; Felisiak-Golabek A; Wang Z; Inaguma S; Lasota J
    Am J Surg Pathol; 2017 May; 41(5):577-585. PubMed ID: 28288036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal stromal tumours (GISTs): a clinicopathological and molecular study of 66 cases.
    Koay MH; Goh YW; Iacopetta B; Grieu F; Segal A; Sterrett GF; Platten M; Spagnolo DV
    Pathology; 2005 Feb; 37(1):22-31. PubMed ID: 15875730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-transcriptional dysregulation by miRNAs is implicated in the pathogenesis of gastrointestinal stromal tumor [GIST].
    Kelly L; Bryan K; Kim SY; Janeway KA; Killian JK; Schildhaus HU; Miettinen M; Helman L; Meltzer PS; van de Rijn M; Debiec-Rychter M; O'Sullivan M;
    PLoS One; 2013; 8(5):e64102. PubMed ID: 23717541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined DNA methylation and gene expression profiling in gastrointestinal stromal tumors reveals hypomethylation of SPP1 as an independent prognostic factor.
    Haller F; Zhang JD; Moskalev EA; Braun A; Otto C; Geddert H; Riazalhosseini Y; Ward A; Balwierz A; Schaefer IM; Cameron S; Ghadimi BM; Agaimy A; Fletcher JA; Hoheisel J; Hartmann A; Werner M; Wiemann S; Sahin O
    Int J Cancer; 2015 Mar; 136(5):1013-23. PubMed ID: 25046773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of the RNA-binding protein RBPMS2 in gastrointestinal stromal tumors.
    Hapkova I; Skarda J; Rouleau C; Thys A; Notarnicola C; Janikova M; Bernex F; Rypka M; Vanderwinden JM; Faure S; Vesely J; de Santa Barbara P
    Exp Mol Pathol; 2013 Apr; 94(2):314-21. PubMed ID: 23295309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synchronous and metachronous multiple gastrointestinal stromal tumors.
    Xu C; Liu YL; Yu HY; Hou YY; Lu SH; Zhao LJ; Zhou Y; Shi Y; Tan YS; Zhu XZ
    Histol Histopathol; 2012 Feb; 27(2):225-34. PubMed ID: 22207557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.